S

cientists have discovered a potential reason why melanoma doesn’t always respond to certain drugs.

For some advanced melanoma patients, immune checkpoint inhibitors — a kind of immunotherapy that pushes the immune system to attack tumors — can lead to long-term remission. But for many patients, the drugs don’t work. Now, scientists at Swiss Federal Institute of Technology in Lausanne studying a mouse model of melanoma have discovered that “bad immune cells” might be limiting how well the drugs work. Their findings were published this week in Science Translational Medicine.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.